• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANIKA ORTHOVISC; SODIUM HYALURONATE FOR INTRA ARTICULATE INJECTION.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANIKA ORTHOVISC; SODIUM HYALURONATE FOR INTRA ARTICULATE INJECTION. Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Muscle Weakness (1967)
Event Date 12/05/2022
Event Type  Injury  
Manufacturer Narrative
This case is still under investigation at the manufacturing site.A supplemental report will be submitted upon receipt of new and relevant information or upon completion of the investigation at the manufacturing site.
 
Event Description
On 15dec2022 anika received a medwatch report (mw5113703) from the fda.The patient was asked "since your last refill, have you been hospitalized?" the patient stated "yes, went to the emergency room with weakness in the left hand".Patient was admitted for observation overnight, diagnosed with possible tia (transient ischemic attack) or peripheral nerve damage.The patient was not experiencing any problems at the time and there was no further information obtained.Patient received an orthovisc injection (procedure was not reported on an unspecified date).There is no specific allegation in the description of the event of an adverse event or malfunction with the orthovisc injection or syringe.The lot number and catalog number were not provided.Contact information was not provided.It is unknown who treated the patient.There was no report of any device malfunction referenced in the report.The current status of the patient is unknown at this time.Anika has reached out to the distributor and this case was not on file.
 
Manufacturer Narrative
This case is still under investigation at the manufacturing site.A supplemental report will be submitted upon receipt of new and relevant information or upon completion of the investigation at the manufacturing site.Additional information the reported issue was not confirmed.The patient reported being hospitalized after receiving an orthovisc injection on an unspecified date.The clinic name and location was not provided.The patient reported weakness in the left hand and was admitted to the hospital for observation for one night.The patient was reportedly diagnosed with possible tia (transient ischemic attack) or peripheral nerve damage.The patient was not experiencing any problems at the time of the orthovisc injection and there was no further information obtained.The lot number was not provided.There was no report of any device malfunction or any unusual appearance with the packaging or device at the time of use.The current status of the patient is unknown.Clinical review of the case details determined that there is insufficient information to determine an association between the intra-injection and the reported complaint.Insufficient information about patient demographics, pre-existing medical history, as well as unknown temporal association of the intra-injection and the complaint.A review of the lots batch record was not performed as the lot number was not provided.All product manufactured by anika and anika entities are released to applicable procedures and specifications.The reported event will continue to be monitored and trended for future analysis.
 
Event Description
On 15dec2022 anika received a medwatch report (mw5113703) from the fda.The patient was asked "since your last refill, have you been hospitalized?" the patient stated "yes, went to the emergency room with weakness in the left hand." patient was admitted for observation overnight, diagnosed with possible tia (transient ischemic attack) or peripheral nerve damage.The patient was not experiencing any problems at the time and there was no further information obtained.Patient received an orthovisc injection (procedure was not reported on an unspecified date).There is no specific allegation in the description of the event of an adverse event or malfunction with the orthovisc injection or syringe.The lot number and catalog number were not provided.Contact information was not provided.It is unknown who treated the patient.There was no report of any device malfunction referenced in the report.The current status of the patient is unknown at this time.Anika has reached out to the distributior and this case was not on file.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORTHOVISC
Type of Device
SODIUM HYALURONATE FOR INTRA ARTICULATE INJECTION.
Manufacturer (Section D)
ANIKA
32 wiggins avenue
bedford MA 01730
Manufacturer Contact
le van
32 wiggins avenue
bedford, MA 01730
MDR Report Key16102560
MDR Text Key306703484
Report Number3007093114-2023-00001
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/15/2022
Initial Date FDA Received01/05/2023
Supplement Dates Manufacturer Received12/15/2022
Supplement Dates FDA Received01/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
81 MG ASPIRIN; 81 MG ASPIRIN; PLAVIX UNKNOWN DOSAGE; PLAVIX UNKNOWN DOSAGE
Patient Outcome(s) Hospitalization;
-
-